Commodore Capital LP Cytokinetics Inc Transaction History

Commodore Capital LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$33.93 - $48.92 $1.32 Million - $1.91 Million	38,994 Added 4.56%	893,646 $35.1 Million
Q1 2022 May 16, 2022	BUY	$29.74 - $46.0 $4.46 Million - $6.91 Million	150,115 Added 21.31%	854,652 $31.5 Million
Q4 2021 Feb 14, 2022	SELL	$34.35 - $46.38 $3.16 Million - $4.27 Million	-92,041 Reduced 11.55%	704,537 $32.1 Million
Q3 2021 Nov 15, 2021	BUY	$18.54 - $35.74 $1.71 Million - $3.3 Million	92,261 Added 13.1%	796,578 $28.5 Million
Q2 2021 Aug 16, 2021	BUY	$19.79 - $26.99 $13.9 Million - $19 Million	704,317 New	704,317 $13.9 Million

410

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.9B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Commodore Capital LP, based on Form 13F filings with the SEC.

Stay updated on Commodore Capital LP with notifications on news.